Wednesday, October 31, 2007

Caliph and Biotech

By Tom Mazanec(vBulletin)
Caliph is given as TL 8 in Biotech. But they have Unaging, which is several
levels higher. How do you get ONE article of a high TL without going through
the intermediate stages in a field?

http://forums.sjgames.com/showthread.php?t=32546&goto=newpost

Steve Jackson Games Forums
http://forums.sjgames.com


Biotech News
AZhttp, Inc.
Biotechnology Marketing

BC biotech breakthroughs Vancouver Sun

Eager investors eye future BC biotech breakthroughs Vancouver Sun - British
Columbia, Canada "I'm back to working full-time," said Galbraith, a partner
at Ventures West who leads the company's biotech portfolio. "I'm predicting
things are going to...

http://www.canada.com/vancouversun/news/business/story.html?id=108a970f-2a6
a-4e73-ae7d-ea38597b924b&k=45318

See all stories on this topic:
http://news.google.com/news?hl=en&ncl=http://www.canada.com/vancouversun/ne
ws/business/story.html%3Fid%3D108a970f-2a6a-4e73-ae7d-ea38597b924b%26k%3D453
18


Biotech News
AZhttp, Inc.
Biotechnology Marketing

What have we got for biotech billions?

The Age - Melbourne,Victoria,Australia
The report -- the Biotechnology Strategic Review -- showed that "Victoria's
biotech sector is now a world leader in many areas, including infectious
disease...

http://www.theage.com.au/news/world/what-have-we-got-for-biotech-billions/2
007/10/27/1192941399344.html

See all stories on this topic:
http://news.google.com/news?hl=en&ncl=http://www.theage.com.au/news/world/w
hat-have-we-got-for-biotech-billions/2007/10/27/1192941399344.html


Biotech News
AZhttp, Inc.
Biotechnology Marketing

Tuesday, October 30, 2007

Biogen Move Raises The Ante On Biotech Deals

CNNMoney.com - USA It would not
surprise me to see Pfizer acquiring a major biotech.
Bannister: It could be Amgen (NASDAQ:AMGN) AMGN , though Amgen is somewhat
large...

http://money.cnn.com/news/newsfeeds/articles/newstex/IBD-0001-20538869.htm

See all stories on this topic:
http://news.google.com/news?hl=en&ncl=http://money.cnn.com/news/newsfeeds/a
rticles/newstex/IBD-0001-20538869.htm


Biotech News
AZhttp, Inc.
Biotechnology Marketing

Biotech Firm Does It Cheaper

Biotech Firm Does It Cheaper, Just Like Other Chinese Companies CNNMoney.com
- USA The biotech industry isn't just a US phenomenon. Yep, China has one,
too, and it's growing about 20% a year. One of China's leading biotech firms
-- 3SBio ...

http://money.cnn.com/news/newsfeeds/articles/newstex/IBD-0001-20538884.htm

See all stories on this topic:
http://news.google.com/news?hl=en&ncl=http://money.cnn.com/news/newsfeeds/a
rticles/newstex/IBD-0001-20538884.htm


Biotech News
AZhttp, Inc.
Biotechnology Marketing

Australian biotech spinoff to develop drugs

By admin
The Australian diagnostics company HealthLinx is spinning off two
therapies in clinical development into a new company--Proaegis
Biosciences--which will hit the road in search of $4 million in fresh
Read more...

http://www.fiercebiotech.com/story/australian-biotech-spinoff-develop-drugs
/2007-10-17?utm_medium=rss&utm_source=rss

http://www.fiercebiotech.com/news/frontpage


Biotech News
AZhttp, Inc.
Biotechnology Marketing

Monday, October 29, 2007

Bio Tech Manufacturing

There seems to be a lot of talk around contract manufacturing of ...
Clarification added October 17, 2007 11:37 AM: This question is
directed more specifically at the North American market, although
thoughts from other regions are most welcome.

http://www.linkedin.com/answers/technology/biotech/TCH_BIO/115448-2709309

LinkedIn Answers: Biotech
http://www.linkedin.com/answers/browse/technology/biotech/TCH_BIO


Biotech News
AZhttp, Inc.
Biotechnology Marketing

Biotech and Beyond

Ten years after the biotech revolution offered new pest control options
to farmers, a lot of people are still concerned about the potential
environmental, food-safety, legal, political and bioethical effects of
large scale releases of ...

http://tango.gnn.tv/blogs/25421/Biotech_and_Beyond

GNN Blogs
http://www.gnn.tv


Biotech News
AZhttp, Inc.
Biotechnology Marketing

Biotech brass plead case

St. Petersburg Times - St. Petersburg,FL,USA
But Lerner and other biotech executives are palpably nervous about
sustaining the state's biotech momentum after the departure of the
industry's biggest ...

http://www.sptimes.com/2007/10/17/Business/Biotech_brass_plead_c.shtml

See all stories on this topic:
http://news.google.com/news?hl=en&ncl=http://www.sptimes.com/2007/10/17/Bus
iness/Biotech_brass_plead_c.shtml


Biotech News
AZhttp, Inc.
Biotechnology Marketing

Thursday, October 25, 2007

7th Annual Regional Biotech Council Annual Conference

PR Leap (press release) - Chula Vista,CA,USA
The mission of the Council is to provide a networking environment for
biotech entrepreneurs as well as small and emerging biotech companies...

http://www.prleap.com/pr/97908/

See all stories on this topic:
http://news.google.com/news?hl=en&ncl=http://www.prleap.com/pr/97908/


Biotech News
AZhttp, Inc.
Biotechnology Marketing

Biotech takeover targets

Globe and Mail - Canada
Citi Investment Research has upped price targets in the biotech sector,
including Biogen Idec Inc., ImClone Systems Inc. and Genzyme Corp. to
reflect the ...

http://www.theglobeandmail.com/servlet/story/RTGAM.20071017.WBmarkets200710
17090912/WBStory/WBmarkets

See all stories on this topic:
http://news.google.com/news?hl=en&ncl=http://www.theglobeandmail.com/servle
t/story/RTGAM.20071017.WBmarkets20071017090912/WBStory/WBmarkets


Biotech News
AZhttp, Inc.
Biotechnology Marketing

Biotech patch offers no-risk birth control

Times Online - UK
A new kind of contraceptive that does not rely on hormones is being
developed, promising women a reliable way of controlling their fertility
without ...

http://women.timesonline.co.uk/tol/life_and_style/health/article2672902.ece

See all stories on this topic:
http://news.google.com/news?hl=en&ncl=http://women.timesonline.co.uk/tol/li
fe_and_style/health/article2672902.ece


Biotech News
AZhttp, Inc.
Biotechnology Marketing

Biotech Corn Rules

Science should be only criteria for setting biotech corn rules
Central Maine Morning Sentinel - Augusta,ME,USA
In December 1998, when the board was considering license applications for
several varieties of biotech-enhanced, insect-resistant corn, Lewis said,
...

http://morningsentinel.mainetoday.com/view/columns/4383300.html

See all stories on this topic:
http://news.google.com/news?hl=en&ncl=http://morningsentinel.mainetoday.com
/view/columns/4383300.html


Biotech News
AZhttp, Inc.
Biotechnology Marketing

Wednesday, October 24, 2007

SBIR Grant

BIO to Ask Congress to Restore SBIR Grant Eligibility for Small ...
Business Wire (press release) - San Francisco,CA,USA
Because of a rule change in 2003, small majority venture-backed biotech
companies are ineligible to compete for SBIR grants. BIO has asked Congress
to ...

http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_vi
ew&newsId=20071017006330&newsLang=en

See all stories on this topic:
http://news.google.com/news?hl=en&ncl=http://home.businesswire.com/portal/s
ite/google/index.jsp%3FndmViewId%3Dnews_view%26newsId%3D20071017006330%26new
sLang%3Den


Biotech News
AZhttp, Inc.
Biotechnology Marketing

Feuerstein's Biotech Mailbag

The Street: Feuerstein's Biotech Mailbag Thanks for returning to the Biotech
Mailbag. I do my best to respond to your comments and questions, so please
email me here. . This week's ...

http://www.inform.com/articles/43488434/?puburl=http%3A%2F%2Fwww.thestreet.
com%2Fs%2Ffeuersteins-biotech-stock-mailbag%2Fnewsanalysis%2Fbiotech%2F10384
286.html%3Fpuc%3D_tsclsii&source=feed

Inform
http://www.inform.com


Biotech News
AZhttp, Inc.
Biotechnology Marketing
ebay affiliate success

Tuesday, October 23, 2007

The Virginia G. Piper Charitable Trust and Flinn Foundation Launch $45 million Initiative to Develop Personalized Diagnostics

Biotech News AZhttp, Inc.

The Virginia G. Piper Charitable Trust and Flinn Foundation Launch $45 million Initiative to Develop Personalized Diagnostics


Nobel laureate Dr. Lee Hartwell, TGen and the Biodesign Institute at ASU to lead Arizona-based global effort to improve patient outcomes and reduce health care costs

10-17-2007

PHOENIX, Oct. 17, 2007 -- Two Arizona-based philanthropic organizations have committed $45 million to fund an innovative initiative to develop personalized molecular diagnostics. The ability to diagnose and treat disease based on every person's unique physiological makeup is critical to enabling physicians to improve health outcomes while at the same time reducing medical costs.
Under the Partnership for Personalized Medicine, The Virginia G. Piper Charitable Trust has committed $35 million and the Flinn Foundation has granted $10 million to bring together a wide range of resources to advance a global personalized medicine initiative.

World-renowned scientist Dr. Lee Hartwell, 2001 Nobel laureate and director of Fred Hutchinson Cancer Research Center, has been recruited to lead this effort. The Hutchinson Center, based in Seattle, is a leader in using molecular diagnostics for the early detection and clinical management of cancer and other diseases. In addition to his current position as president and director of Fred Hutchinson Cancer Research Center, he will chair the Partnership executive committee, which includes Dr. George Poste, director of the Biodesign Institute at Arizona State University, and Dr. Jeffrey Trent, president and scientific director of the Translational Genomics Research Institute (TGen).

"It is a tremendous opportunity for me to be a part of this new model for improving health while reducing health care costs that is being funded by the Piper and Flinn foundations," Hartwell said. "The collaboration between TGen, the Biodesign Institute at ASU, other institutions in Arizona and Fred Hutchinson Cancer Research Center brings together enormous expertise to tackle major challenges in bringing new science and technology to disease management."

The cornerstone of the Partnership is the creation of the Virginia G. Piper Center for Personalized Diagnostics that draws upon the scientific strengths of two of the state's leading bioscience entities, TGen and the Biodesign Institute at ASU, each of which will contribute significant laboratory space to the effort. The Piper Center will utilize bioinformatics and high-performance computing expertise at both institutions, existing nanotechnology and imaging expertise at the Biodesign Institute, and supercomputing resources through ASU's Ira A. Fulton School of Engineering.

Additionally, an industrial scale, high-throughput proteomics production facility will be established that taps expertise at both TGen and the Biodesign Institute at ASU in robotics, protein analysis and computing.

Hartwell's involvement provides the Piper Center with opportunity to draw on the Hutchinson Center's extensive capabilities in health economics and the design of clinical and public-health trials through consultative and collaborative relationships.

"The Piper trustees made this investment because Dr. Hartwell has a vision to transform the prevention, diagnosis and treatment of disease," said Dr. Judy Jolley Mohraz, president and CEO of the Piper Trust. "That vision draws together scientists, clinicians, engineers, statisticians, insurers and regulators to work collectively to make health care more targeted and affordable. This initiative holds the promise of making a difference in the quality of life for people here in Arizona and throughout the world."

According to John Murphy, president and CEO of the Flinn Foundation, biomarker discovery and diagnostic development could ultimately lead to earlier disease detection and more precise disease management. "To leverage Arizona's institutional assets, the Flinn Foundation's grant commitment to TGen will link Arizona's research universities, health care providers, research institutes and industry partners throughout the state to support the collection and storage of biospecimens and drive Arizona-centric demonstration projects," Murphy said.

Approximately 50 percent of the Flinn Fund for Arizona Proteomics Research will be available to promote research collaborations to leverage the state's significant institutional resources in this field, Murphy added, with the balance supporting the creation of a high-throughput proteomics production facility.

Proteomics is a promising and cutting-edge field that studies proteins and their functions in the body. The proteomics production facility will focus on discovering new proteins for the development of diagnostic tests for patients with cancer or other illnesses. These tests could ultimately lead to earlier disease detection and more precise disease management.

Even though the necessary technologies to develop personalized diagnostic tests are available, barriers such as the expense of clinical trials and difficulty obtaining clinical samples have significantly slowed the development process. The Partnership will focus on the development, testing and validation of new molecular diagnostic tools and the approval and distribution of these tools for widespread clinical use. This will be accomplished through a series of collaborative demonstration projects that integrate key health organizations.

"The Holy Grail of personalized medicine includes blood-based tests that improve diagnosis and help direct clinical care," said Trent. "The unparalleled opportunity the Partnership provides is to expand the magnitude of proteomic studies across a spectrum of key clinical questions."

The Partnership includes recruitment of new faculty and will engage national and international partners to ensure developments are rapidly commercialized.

"With the team of scientific and clinical research excellence we are assembling, our goal is to transform medicine from the current 'one size fits all' approach to one that is targeted around a patient's unique genetic and molecular profile," Poste said.

Partnerships formed with large health care systems and disease-focused foundations will facilitate the implementation and validation of molecular diagnostics in clinical settings, as well as close ongoing interaction between scientists and clinicians. Health care systems will benefit from newly developed diagnostics through the most cost-effective use of medical treatments, while patients and the public in general will enjoy greater overall health outcomes.

ASU President Michael Crow added that this endeavor "promises to become a shining example of how multiple partners can work together to address a critical need in human health and accelerate solutions that extend beyond our own community."

###

About The Virginia G. Piper Charitable Trust
A private foundation, The Virginia G. Piper Charitable Trust is dedicated to honoring Virginia Galvin Piper's philanthropic commitment to changing lives and strengthening community in Maricopa County. By investing in nonprofits and encouraging strategic planning for the future, the Trust strives to make Maricopa County a stronger, more nurturing and vibrant community. For more information, visit www.pipertrust.org.

About the Flinn Foundation
The Flinn Foundation is an independent grant-making charity established by a Phoenix physician and his wife (Robert S. and Irene P. Flinn) in 1965. It is dedicated to improving the quality of life in Arizona principally by advancing the medical sciences. It fulfills this mission through its support of various scientific and educational programs and activities, including the Flinn Scholars program. For more information, visit www.flinn.org.

About TGen
TGen is a nonprofit 501(c)(3) organization focused on developing earlier diagnoses and smarter treatments. Translational genomics research is a relatively new field employing innovative advances arising from the Human Genome Project and applying them to the development of diagnostics, prognostics and therapies for cancer, neurological disorders, diabetes and other complex diseases. TGen's research is based on personalized medicine. The institute plans to accomplish its goals through robust and disease-focused research. For more information, visit www.tgen.org.

About the Biodesign Institute at Arizona State University
The Biodesign Institute at ASU integrates diverse fields of science to cure and prevent disease, overcome the limitations of injury, renew the environment and improve national security. By fusing research in biology, engineering, medicine, physics, information technology and cognitive science, the institute accelerates discoveries into uses that can be adopted rapidly by the private sector. For more information, visit www.biodesign.asu.edu.

About Fred Hutchinson Cancer Research Center
At Fred Hutchinson Cancer Research Center, interdisciplinary teams of world-renowned scientists and humanitarians work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Hutchinson Center researchers, including three Nobel laureates, bring a relentless pursuit and passion for health, knowledge and hope to their work and to the world. For more information, visit www.fhcrc.org.


Internet Marketing

Biogen's

How big is biotech? Biogen's worth $20 billion By DavidBrooks Or so the
company hopes as it considers outsider buyers, says the Globe. The company
has 4000 employees, including 1750 in Massachusetts.
Not exactly small change.

http://www.area603.com/index.php?op=ViewArticle&articleId=1451&blogId=6

GraniteGeek
http://www.area603.com/index.php?blogId=6


Biotech News
AZhttp, Inc.
Biotechnology Marketing

Kannapolis

Business leaders: Funding key to biotech growth - Kannapolis ...
Cabarrus Business & Lifestyles Magazine Business leaders: Funding key to
biotech growth Kannapolis Independent Tribune, NC - 6 hours ago Clyde Higgs,
vice president for business development for Castle & Cooke, warned that lack
of ...

http://www.personalbee.com/261/20888996

BEE: Venture Capital And Startups
http://www.personalbee.com/261


Biotech News
AZhttp, Inc.
Biotechnology Marketing

Monday, October 22, 2007

LSFI Center For Advanced Education Services

Department of Nano-Biotechnology

ADMISSION NOTICE 2007-08

PG Diploma in NanoBiotechnology

INTRODUCTION

LSFI is one of the non-profit organization established for the promotion and popularization of the emerging areas of science and technology. As part of its educational programmes, LSFI is introducing a new, innovative and cutting edge curricula based Post-Graduate Diploma Course in Nano-Biotechnology through distance mode with the excellent expertise. Nanobiotechnology being the new wave, has the tremendous scope in advanced biomedical research demanding high-tech skill based technical approaches such as genetic engineering, tissue engineering, nanoengineering etc, which explores the excellent and greater career prospects and employment opportunities.

FEATURES OF COURSE

Ø Excellent career prospects and employment opportunities.
Ø This course is for the period of one academic year.
Ø The course is focused on the essential fundamental knowledge about the nanobiotechnology and its advanced biomedical applications, covering many topics like current research interest such as medical nanorobotics , artificial organ , DNA chip, smart bomb for cancer, nanodiagnostic tool for cancer , treatment nanosystem for heart, nanosurgeries, nanomanipulation system, nanofabrication, synthesis of nanomaterials,Nano drug delivery system, nanobiotechnology for HIV virus and its diagnosis and treatment, etc.
Ø The study material (books) will be provided from the department.
Ø Students need to submit project / dissertation / assignment for the fulfillment of the course.
Ø Students may be placed for the industrial internships / workshops depending on the availability of the opportunities.


ELIGIBILITY

Ø Graduates / Post-graduates / Part-Time / Working professionals / Young Scientists with Life sciences disciplines background are eligible.
Ø Candidates from Biotechnology, Microbiology, Pharmacy, MBBS, Nursing, BioChemistry, Biology, Engineering, Agriculture, Veterinary and other disciplines with keen interest are all eligible.
Ø Age shall be above 18 years, with minimum 45 % in any of the qualifying examination.

HOW TO APPLY

Ø Interested students may obtain the prescribed Application Form by sending Demand Draft (DD) of Rs. 200/- to “LSFI office, Dept of Nanobiotechnology, Morigeri – 583220” by ordinary post only.
Ø One self-addressed envelope (9 X 12 inches) affixed with Rs. 10 stamps may be enclosed.
Ø DD shall be drawn in favour of “Director, Department of Nanobiotechnology, LSFI” payable at “State Bank of Mysore, Huvinahadagali (Branch code is 4-0122)”.
Ø Candidate are advised to write their name and address on the backside of the Bank Draft.

LAST DATE

v Obtaining / Submission of application form: From 1st Sept, 2007 - 30th Nov, 2007

Biotech News
AZhttp, Inc.
Biotechnology Marketing

Department of Nano-Biotechnology

Applications are invited for the admission to a new "PG Diploma in Nanobiotechnology" Course which is first of its kind in India from LSFI Center for Advanced Education Services (LSFI for AES), Morigeri - 583220, Karnataka, India.

Nanobiotechnology being the new wave, has the tremendous scope in advanced biomedical and many other fields with the excellent and greater career prospects and opportunities.

How to apply: Obtain the application forms by post and submit the same on or before 31st, November 2007.

We request you to forward the same notice to your students / friends / colleagues etc.

Thanking you, with deep regards
Krunal R Chopra
Director, Department of NanoBiotechnology
LSFI Center For Advanced Education Services
Admin. Off: Morigeri - 583220, Karnataka, India
Email: nanobiotek@yahoo.com;
Web: www.lifescience.org.in
Tel: 09427932947

All Contributions to LSFI are eligible for Income Tax Exemption u/s 80G
Vide letter F. No.32/80G/CIT-GLB/06-07


Biotech News
AZhttp, Inc.
Biotechnology Marketing

Friday, October 19, 2007

Biotech in Toronto?

FYI everyone, the Nige is from Quebec...so apparently lots of US Dako
employees have had plenty of interaction with a non-Celine Quebecois...and
could explain some of the general PQ disdain!

http://www.biofind.com/Rumor/Default.aspx?ID=120864

Biofind Rumor Mill Posts
http://www.biofind.com/


Biotech News
AZhttp, Inc.
Biotechnology Marketing

Frazer on biotech road show

Therapeutics Daily (subscription) (press release) - Newtown,PA,USA PROFESSOR
Ian Frazer is among a group of ``celebrity'' scientists set to embark on a
public lecture tour to promote Queensland's emerging biotechnology ...

http://www.therapeuticsdaily.com/news/article.cfm?contentValue=1554397&cont
entType=sentryarticle&channelID=26

See all stories on this topic:
http://news.google.com/news?hl=en&ncl=http://www.therapeuticsdaily.com/news
/article.cfm%3FcontentValue%3D1554397%26contentType%3Dsentryarticle%26channe
lID%3D26


Biotech News
AZhttp, Inc.
Biotechnology Marketing

Thursday, October 18, 2007

PBAU

PBAU offers new science degree amid biotech rise Palm Beach Post - FL,
United States "As we look at the national and local scene, the growth areas
are in chemistry, pharmaceuticals and biotech." University trustees approved
the new degree in ...

http://www.palmbeachpost.com/politics/content/local_news/epaper/2007/10/13/
w1c_PBA_1013.html

See all stories on this topic:
http://news.google.com/news?hl=en&ncl=http://www.palmbeachpost.com/politics
/content/local_news/epaper/2007/10/13/w1c_PBA_1013.html


Biotech News
AZhttp, Inc.
Biotechnology Marketing

Feuerstein's Biotech-Stock Mailbag

TheStreet.com - USA
By Adam Feuerstein BOSTON -- Thanks for returning to the Biotech Mailbag. I
do my best to respond to your comments and questions, so please email me
here. ...

http://www.thestreet.com/s/feuersteins-biotech-stock-mailbag/newsanalysis/b
iotech/10384286.html?puc=googlefi

See all stories on this topic:
http://news.google.com/news?hl=en&ncl=http://www.thestreet.com/s/feuerstein
s-biotech-stock-mailbag/newsanalysis/biotech/10384286.html%3Fpuc%3Dgooglefi


Biotech News
AZhttp, Inc.
Biotechnology Marketing

Sibal Hindu Business Line

Proposed biotech policy to be finalised in two weeks: Sibal Hindu Business
Line - India NEW DELHI: The government on Saturday said it would finalise
the framework for the proposed biotech policy that seeks to incentivize
research and...

http://www.thehindubusinessline.com/businessline/blnus/14131801.htm

See all stories on this topic:
http://news.google.com/news?hl=en&ncl=http://www.thehindubusinessline.com/b
usinessline/blnus/14131801.htm


Biotech News
AZhttp, Inc.
Biotechnology Marketing

Wednesday, October 17, 2007

Hawaii Biotech seeks vaccine trials

'Aiea-based Hawaii Biotech has filed an application with the US Food and
Drug Administration to conduct human clinical trials for a West Nile virus
vaccine...

http://the.honoluluadvertiser.com/article/2007/Oct/10/bz/hawaii710100403.ht
ml

The Honolulu Advertiser: Business
http://www.honoluluadvertiser.com/business


Biotech News
AZhttp, Inc.
Biotechnology Marketing

Biotech Buyouts Likely to Continue

By buying into biotech companies, big pharma and giant biotech companies
will deepen their pipelines and sustain growth in the long run...

http://www.zacks.com/newsroom/commentary/index.php?id=6089

Zacks.com: Analyst Interview
http://www.zacks.com/


Biotech News
AZhttp, Inc.
Biotechnology Marketing

Tuesday, October 16, 2007

Biotech Firm Telomolecular Corp

Biotech Firm Telomolecular Corp. Will Build $43 Million Facility ...
RANCHO CORDOVA, Calif.--(BUSINESS WIRE)--Telomolecular Corporation
(www.telomolecular.com) announced today its plans to build a 140000 sq.
ft. facility budgeted at $43 million dollars in West Baton Rouge Parish
(www.wbrcouncil.org) ...

http://www.biospace.com/news_story.aspx?StoryID=72851&full=1

BioSpace.com Featured News
http://www.biospace.com/


Biotech News
AZhttp, Inc.
Biotechnology Marketing

BIOTECH STOCKS

BIOTECH STOCKS Drug stocks mixed; Angiotech climbs on FDA update MarketWatch
- USA By Val Brickates Kennedy, MarketWatch BOSTON (MarketWatch) --
Benchmarks for both the biotechnology and pharmaceutical sectors were mixed
Wednesday, ...

http://www.marketwatch.com/news/story/drug-stocks-mixed-angiotech-climbs/st
ory.aspx?guid=%7B44B7B24E-F417-4C94-85BC-93E09CEDC14E%7D

See all stories on this topic:
http://news.google.com/news?hl=en&ncl=http://www.marketwatch.com/news/story
/drug-stocks-mixed-angiotech-climbs/story.aspx%3Fguid%3D%257B44B7B24E-F417-4
C94-85BC-93E09CEDC14E%257D


Biotech News
AZhttp, Inc.
Biotechnology Marketing

Bethesda biotech to move to Baltimore

Bethesda biotech to move to Baltimore research park Bizjournals.com -
Charlotte,NC,USA ... said in a statement the deal with Cangen builds on the
development's
objectives: Attracting promising biotech companies interested in utilizing
the ...

http://www.bizjournals.com/washington/stories/2007/10/08/daily21.html

See all stories on this topic:
http://news.google.com/news?hl=en&ncl=http://www.bizjournals.com/washington
/stories/2007/10/08/daily21.html


Biotech News
AZhttp, Inc.
Biotechnology Marketing

Monday, October 15, 2007

Trinity Biotech to delist from Irish bourse Reuters - USA Trinity Biotech
said in a statement the move was expected to take effect from Nov. 5. "This
will have no effect on the Nasdaq listing of the company upon...

http://www.reuters.com/article/companyNewsAndPR/idUSL0955886320071009

See all stories on this topic:
http://news.google.com/news?hl=en&ncl=http://www.reuters.com/article/compan
yNewsAndPR/idUSL0955886320071009


Biotech News
AZhttp, Inc.
Biotechnology Marketing

Biotech Firm Telomolecular

Biotech Firm Telomolecular Will Build Facility in Louisiana to ...
Business Wire (press release) - San Francisco,CA,USA Dollar continues, "We
are dedicated to building one of the most competitive biotech workforce
training initiatives in the country...

http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_vi
ew&newsId=20071010005844&newsLang=en

See all stories on this topic:
http://news.google.com/news?hl=en&ncl=http://home.businesswire.com/portal/s
ite/google/index.jsp%3FndmViewId%3Dnews_view%26newsId%3D20071010005844%26new
sLang%3Den


Biotech News
AZhttp, Inc.
Biotechnology Marketing

Houston firms

Houston firms get nearly $4 million in biotech grants Houston Chronicle -
United States AUSTIN -- Gov. Rick Perry on Tuesday announced more than $3.8
million in state grants to four Houston-area biotechnology companies...

http://www.chron.com/disp/story.mpl/metropolitan/5201652.html

See all stories on this topic:
http://news.google.com/news?hl=en&ncl=http://www.chron.com/disp/story.mpl/m
etropolitan/5201652.html


Biotech News
AZhttp, Inc.
Biotechnology Marketing

Friday, October 12, 2007

Bitoech activity 8.10.2007

By Helge V. Keitel(Helge V. Keitel)
This has been an active day. I've been blogging about biotech and there has
been a lot of traffic. I moved old blogs from Kymijoki Virtaa to this blog.
This is a part of my channel arrangement. The idea is to focus more on
specific...

http://smartroad.blogspot.com/2007/10/bitoech-activity-8102007.html

Wood Bioenergy Bioreactors Biotechnology
http://smartroad.blogspot.com/


Biotech News
AZhttp, Inc.
Biotechnology Marketing

Bolder BioTechnology on a Roll

By Adam(Adam)
Bolder BioTechnology, uses advanced protein engineering technologies to
create proprietary, long-acting human protein pharmaceuticals for the
treatment of hematopoietic and endocrine disorders, cancer and infectious
diseases...

http://rnaventures.blogspot.com/2007/10/bolder-biotechnology-on-roll.html

Colorado Life Science Deal Flow
http://rnaventures.blogspot.com/


Biotech News
AZhttp, Inc.
Biotechnology Marketing

Working in the Biotechnology Business

Investing in Biotech ...
Advice for anyone wanting to get involved in the biotechnology business.
Resources for planning an education, job hunting, or investing in biotech...

http://biotech.about.com/od/businessadminstration/u/GetInvolved.htm

About.com Biotech / Biomedical:...
http://biotech.about.com/


Biotech News
AZhttp, Inc.
Biotechnology Marketing

New Biotechnology Invention Could Eliminate MRSA

New Biotechnology Invention Could Eliminate MRSA from Hospitals says
LONDON--(BUSINESS WIRE)--British scientists have launched a biotechnology
device which new research shows can kill the MRSA superbug and other
bacteria and viruses, including H5N1, within minutes. Unlike air filtration
systems,...

http://www.devicespace.com/news_story.aspx?StoryID=72534&full=1

DeviceSpace.com Medical Device All News
http://www.devicespace.com/


Biotech News
AZhttp, Inc.
Biotechnology Marketing

Thursday, October 11, 2007

New Biotechnology Invention Could Eliminate MRSA from Hospitals ...

By EuroInvestor.co.uk
British scientists have launched a biotechnology device which new research
shows can kill the MRSA ´superbug´ and other bacteria and viruses, including
H5N1, within minutes. Unlike air filtration sy.. - Read more.

http://www.euroinvestor.co.uk/News/ShowNewsstory.aspx?StoryID=9635426

Financial news - EuroInvestor.co.uk
http://www.euroinvestor.co.uk/


Biotech News
AZhttp, Inc.
Biotechnology Marketing

Wednesday, October 10, 2007

Zimbabwe: 'Embrace Biotechnology to Enhance Agric Productivity'

AllAfrica.com - Washington,USA
Zimbabweans should embrace biotechnology to enhance agricultural
productivity and achieve economic development, Minister of Science and
Technology Dr Olivia...

http://allafrica.com/stories/200710080247.html

See all stories on this topic:
http://news.google.com/news?hl=en&ncl=http://allafrica.com/stories/20071008
0247.html


Biotech News
AZhttp, Inc.
Biotechnology Marketing

Tuesday, October 09, 2007

ARIUS to present at 15th annual BioPartnering

ARIUS to present at 15th annual BioPartnering Europe conference Canada
NewsWire (press release) - Canada The BioPartnering Europe conference offers
attendees an opportunity to meet face-to-face with key players in the
pharmaceutical and biotechnology industry...

http://www.newswire.ca/en/releases/archive/October2007/08/c9418.html

See all stories on this topic:
http://news.google.com/news?hl=en&ncl=http://www.newswire.ca/en/releases/ar
chive/October2007/08/c9418.html


Biotech News
AZhttp, Inc.
Biotechnology Marketing

Wyeth Pharmaceuticals Acquires Haptogen Ltd. to Boost ...

CNNMoney.com - USA
This acquisition significantly increases Wyeth's already robust
biotechnology drug discovery capabilities. "Haptogen brings to Wyeth a suite
of...

http://money.cnn.com/news/newsfeeds/articles/prnewswire/NYF02905102007-1.htm

See all stories on this topic:
http://news.google.com/news?hl=en&ncl=http://money.cnn.com/news/newsfeeds/a
rticles/prnewswire/NYF02905102007-1.htm


Biotech News
AZhttp, Inc.
Biotechnology Marketing

Competitive Technologies Elects Rus Howard

Competitive Technologies Elects Rus Howard to Board CNNMoney.com - USA
Previously, he served as president and CEO of BioWorks Inc., a biotechnology
company he founded to develop, produce, and sell products that replace
chemical...

http://money.cnn.com/news/newsfeeds/articles/primenewswire/128216.htm

See all stories on this topic:
http://news.google.com/news?hl=en&ncl=http://money.cnn.com/news/newsfeeds/a
rticles/primenewswire/128216.htm


Biotech News
AZhttp, Inc.
Biotechnology Marketing

Monday, October 08, 2007

BIOIDENT Wins Illustrious 2007 Wall Street Journal Technology Innovation Awards

Printed Semiconductor-Based Technology Named Co-Winner for Breakthrough Lab-on-a-Chip with Real-Time Results
BIOIDENT Technologies Inc., the leading company in the development of printed opto-electronic solutions for life sciences, today announced that the company is a co-winner in the semiconductor category for the seventh annual Wall Street Journal contest for Technology Innovation. BIOIDENT was awarded for the development of its PhotonicLab(TM) Platform, which enables rapid in-vitro diagnostics, chemical and biological threat detection, and environmental testing without the need for off-site lab analysis.
"We are delighted to win this prestigious award that recognizes our innovative work on the cutting edge of nanotechnology," said Dr. Wasiq Bokhari, CEO for BIOIDENT. "Once again, BIOIDENT is being acknowledged as the pioneer in applying its unique printed opto-electronics to real-world applications. We will continue to leverage our unique technology to develop new solutions to address major industry challenges."
Utilizing the latest breakthroughs in science and nanotechnology, the BIOIDENT PhotonicLab Platform is used to produce the world's first disposable photonic lab-on-a-chip solution for next-generation mobile analytics applications, such as water and food analysis, chemical and biological agent detection, and point-of-care diagnostics. BIOIDENT employs a process developed by its parent company, Austria's NANOIDENT Technologies AG, for using an inkjet printer to print electronic circuits on a variety of surfaces, such as plastic foil or glass; the technology makes it possible to apply photosensitive semiconductors directly onto a lab-on-a-chip. The Platform eliminates the need for complex and expensive readout systems and delivers unprecedented mobility and sensitivity based on existing biological and chemical assays.
About The Wall Street Journal Technology Innovation Awards
As part of the 2007 award nomination process, The Wall Street Journal screened more than 800 applications, narrowing the field to about 150 entries. A panel of 13 judges picked category winners and runners-up in 12 different entry categories including computing systems, energy, environment, materials and other base technologies, media/broadcasting, medical research, medical devices, network/internet technologies, network security, semiconductors, software and transport. Each entrant was required to offer extensive details and explain why the entry merited consideration. Judging criteria included innovativeness, clarity of explanation, whether the innovation was covered by patents and if it had achieved some measure of success. Factors the panel considered included: the innovation should have gone well beyond what already existed and cannot simply represent incremental improvements; it needed to address major challenges for which new solutions would have a wide-ranging impact in a particular industry; the written application needed to be supported by rigorous data rather than unsubstantiated claims of potential.
About BIOIDENT Technologies Inc.
BIOIDENT is the leader in the development of rapid, multi-assay and mobile analytical and diagnostic systems. BIOIDENT integrates highly sensitive printed photodetectors and electronics with various existing Lab-on-a-Chip (LOC) technologies including lateral flow, microfluidics and microarrays. BIOIDENT's systems are designed for applications in in-vitro diagnostics, chemical and biological threat detection, and environmental testing. BIOIDENT's award-winning PhotonicLab(TM) Technology Platform eliminates the need for complex and expensive readout systems and delivers unprecedented mobility and sensitivity based on existing biological and chemical assays. Benefits for BIOIDENT's customers and partners include high mobility, rapid testing, multiplexing and low cost of ownership.
BIOIDENT is a subsidiary of Austrian-based NANOIDENT Technologies AG, the world leader in printed opto-electronics. The company is privately held with headquarters in Menlo Park, California. BIOIDENT leverages NANOIDENT's SEMICONDUCTOR 2.0(TM) Platform technology and its high-speed manufacturing process, which uses liquid conductive and semi-conductive materials to print electronic circuits on almost any surface using an inkjet printer. NANOIDENT also has the world's only dedicated organic fabrication facility with a production output of 40,000 sq.m per year. For more information about the company, please visit www.bioident.com.


Biotech News
AZhttp, Inc.
Biotechnology Marketing

Friday, October 05, 2007

New Male Contraceptives Under Development

New Male Contraceptives Under Development The recently concluded second
Future of Male Contraception conference highlighted the progress in the
developments of male contraceptives. Among those that have promising
potential: DepoProvera. It seems to be 90% effective,...

http://www.biotech-weblog.com/50226711/new_male_contraceptives_under_develo
pment.php

The Biotech Weblog
http://www.biotech-weblog.com/


Biotech News
AZhttp, Inc.
Biotechnology Marketing

Nucleic acids: DNA vs RNA

By molbioandbiotech
I know this is very elementary and any high school student must be knowing
the differences between RNA and DNA. But I feel a blog which deals with
diverse aspects of molecular biology and biotechnology deserves a mention of
basic ...

http://molbioandbiotech.wordpress.com/2007/09/29/nucleic-acids-dna-vs-rna/

Blogging About Mol Bio and Biotech
http://molbioandbiotech.wordpress.com


Biotech News
AZhttp, Inc.
Biotechnology Marketing

Thursday, October 04, 2007

New biotech centre

New biotech centre to create industrial partnerships By news@neurope.eu The
launch of the University of Copenhagens new centre for research in nature
health and science is to lift up the Danish level and make Danish research
more competitive internationally Copenhagen Capacity reported on September
25...

http://www.neurope.eu/articles/78196.php

New Europe News: The European...
http://www.neurope.eu


Biotech News
AZhttp, Inc.
Biotechnology Marketing

Indian real estate

Indian real estate is no longer relying purely on the IT sector to ...
By Ravi Karandeekar(Ravi Karandeekar)
An estimated 100 million sq. ft of space would be required by the
biotechnology industry by 2010. As in the case of IT, biotech parks would
house manufacturing units within a self-supporting, integrated complex. ...

http://ravikarandeekarsblog.blogspot.com/2007/09/indian-real-estate-is-no-l
onger-relying.html

Ravi Karandeekar's Pune Real...
http://ravikarandeekarsblog.blogspot.com/


Biotech News
AZhttp, Inc.
Biotechnology Marketing

Wednesday, October 03, 2007

Nelson:

Presentation might help lure biotech Online Athens (subscription) -
Athens,GA,USA Tydings attended a presentation and tour of the Research
Triangle (the name for the area between Raleigh, Chapel Hill and Durham)
where many coveted biotech...

http://www.onlineathens.com/stories/093007/business_20070930015.shtml

See all stories on this topic:
http://news.google.com/news?hl=en&ncl=http://www.onlineathens.com/stories/0
93007/business_20070930015.shtml


Biotech News
AZhttp, Inc.
Biotechnology Marketing

FOCUS:

Chemical giant diversifies biotech portfolio Indianapolis Business
Journal - Indianapolis,IN,USA By 2015, Peribere hopes to oversee a balanced
portfolio of agricultural chemical and biotech products. "We're in the stone
age of biotechnology," he said...

http://cms.ibj.com/ASPXPages/6iframes/FrontEndArticlesDetailPage.aspx?Artic
leID=05001&NoFrame=1

See all stories on this topic:
http://news.google.com/news?hl=en&ncl=http://cms.ibj.com/ASPXPages/6iframes
/FrontEndArticlesDetailPage.aspx%3FArticleID%3D05001%26NoFrame%3D1


Biotech News
AZhttp, Inc.
Biotechnology Marketing

Tuesday, October 02, 2007

Sector Roundup: Homebuilders, Biotech

Forbes - NY,USA
AP 09.28.07, 4:54 PM ET NEW YORK (AP) - Shares of homebuilders traded mixed
Friday, concluding a week of bad news for the slumping housing market...

http://www.forbes.com/feeds/ap/2007/09/28/ap4168774.html

See all stories on this topic:
http://news.google.com/news?hl=en&ncl=http://www.forbes.com/feeds/ap/2007/0
9/28/ap4168774.html


Biotech News
AZhttp, Inc.
Biotechnology Marketing

Feuerstein's Biotech-Stock Mailbag

TheStreet.com - USA
By Adam Feuerstein Welcome back to the Mailbag, which unfortunately was
closed most of the week because I was in New York at the UBS Global Life
Sciences ...

http://www.thestreet.com/s/feuersteins-biotech-stock-mailbag/newsanalysis/p
harmaceuticals/10382014.html?puc=_googlen?cm_ven=GOOGLEN&cm_cat=FREE&cm_ite=
NA

See all stories on this topic:
http://news.google.com/news?hl=en&ncl=http://www.thestreet.com/s/feuerstein
s-biotech-stock-mailbag/newsanalysis/pharmaceuticals/10382014.html%3Fpuc%3D_
googlen%3Fcm_ven%3DGOOGLEN%26cm_cat%3DFREE%26cm_ite%3DNA


Biotech News
AZhttp, Inc.
Biotechnology Marketing

Upstream Processes in Antibody Production

Upstream Processes in Antibody Production: Evaluation of Critical ...
Jain, Era , Kumar, Ashok.

http://www.sciencedirect.com/science?_ob=GatewayURL&_origin=IRSSCONTENT&_me
thod=citationSearch&_piikey=S0734975007000985&_version=1&md5=6a04ee35db2a2c3
125778a328b7760b5

ScienceDirect Publication: Biotechnol...
http://www.sciencedirect.com


Biotech News
AZhttp, Inc.
Biotechnology Marketing

Shire deal might create 650 jobs

Boston Globe - United States
The bill gained attention this summer when the Globe revealed that a former
Patrick administration official, Robert Coughlin, met with biotechnology ...

http://www.boston.com/news/local/articles/2007/09/20/shire_deal_might_creat
e_650_jobs

See all stories on this topic:
http://news.google.com/news?hl=en&ncl=http://www.boston.com/news/local/arti
cles/2007/09/20/shire_deal_might_create_650_jobs

Biotech News
AZhttp, Inc.
Biotechnology Marketing

NC State opens biomanufacturing center

BusinessWeek - USA
The NC Biotechnology Center and Department of Commerce also are involved in
the effort. "This type of education and training exists nowhere else in the
...

http://www.businessweek.com/ap/financialnews/D8ROP7K81.htm

See all stories on this topic:
http://news.google.com/news?hl=en&ncl=http://www.businessweek.com/ap/financ
ialnews/D8ROP7K81.htm


Biotech News
AZhttp, Inc.
Biotechnology Marketing

Professor Jonathan Dordick honored

Professor Jonathan Dordick honored by the American Chemical Society
Rensselaer Polytechnic Institute - Troy,NY,USA The award, given annually, is
the ACS's highest biotechnology honor and is designated for a researcher who
has made a substantial impact over the continuum ...

http://news.rpi.edu/update.do?artcenterkey=2314

See all stories on this topic:
http://news.google.com/news?hl=en&ncl=http://news.rpi.edu/update.do%3Fartce
nterkey%3D2314

Biotech News
AZhttp, Inc.
Biotechnology Marketing

Monday, October 01, 2007

Oxide ore and sulphide ore

What is the difference between basic oxide ore and sulphide ore ...
We are interested in the basic chemical bonding of oxides as opposed to
sulphides as relates to the crushing and seperating of each type of raw
ore/material and the subsequent metals recovery methods needed. This
information is needed ...

http://www.linkedin.com/answers/technology/biotech/TCH_BIO/101744-16203667

LinkedIn Answers: Biotech
http://www.linkedin.com/answers/browse/technology/biotech/TCH_BIO


Biotech News
AZhttp, Inc.
Biotechnology Marketing

Invest in Biotech

A guide to getting started investing money in biotech with things to
consider before investing in biotech companies or buying biotechnology
stocks.

http://biotech.about.com/od/investinginbiotech/ht/investing.htm

About.com Biotech / Biomedical:...
http://biotech.about.com/


Biotech News
AZhttp, Inc.
Biotechnology Marketing
Blog Awards